Publications from the National Academies of Sciences, Engineering, and Medicine provide objective and straightforward advice to decision makers and the public. This site includes Health and Medicine Division (HMD) publications released after 1998. A complete list of HMD’s publications from its establishment in 1970 to the present is available as a PDF.
Critical Needs and Gaps in Understanding Prevention ...
Released: April 20, 2011
A single tick bite can have debilitating consequences. Lyme disease is the most common disease carried by ticks in the United States, and the number of those afflicted is growing steadily. If left untreated, the diseases carried by ticks—known as tick-borne diseases—can cause severe pain, fatigue, neurological problems, and other serious health problems. The IOM held a workshop October 11-12, 2010, to examine the state of the science in Lyme disease and other tick-borne diseases.
The National Cancer Policy Summit: Opportunities and ...
Released: February 28, 2011
Technological advances are altering the way cancer research is conducted and cancer care is delivered, and research increasingly is an international effort. At the same time, research budgets are shrinking and the cost of care is growing. The National Cancer Policy Summit brought together leaders in the cancer community to discuss these changes in research and care. Participants suggested many potential actions to provide more patient-centered cancer care, foster more collaboration, and achieve other goals to improve research and care.
Nanotechnology and Oncology – Workshop Summary : Health ...
Released: February 25, 2011
One way scientists are working to overcome challenges in cancer treatment and improve cancer care is through nanotechnology. The National Cancer Policy Forum held a workshop July 12-13, 2010, to explore challenges in the use of nanotechnology in oncology.
Preventing Transmission of Pandemic Influenza and Other ...
Released: January 27, 2011
In 2009, the H1N1 influenza pandemic brought to the forefront the many unknowns about the virulence, spread, and nature of the virus, as well as questions regarding personal protective equipment (PPE) for healthcare personnel. In this report, the IOM assesses the progress of PPE research and identifies future directions for PPE for healthcare personnel.
Sex Differences and Implications for Translational ...
Released: December 10, 2010
Biological differences between the sexes influence not only individual health but also public health, biomedical research, and health care. The IOM held a workshop March 8-9, 2010, to discuss sex differences and their implications for translational neuroscience research, which bridges the gap between scientific discovery and application.
Future Opportunities to Leverage the Alzheimer's Disease ...
Released: December 10, 2010
Nearly 5.3 million Americans are living with Alzheimer’s disease, and 26.6 million people are affected worldwide. The Alzheimer’s Disease Neuroimaging Initiative (ADNI), a public-private partnership, provides a publicly available, international database of clinical and imaging data to foster research and collaboration on Alzheimer’s research worldwide. The IOM held a workshop on July 12, 2010, to explore opportunities to use information from and partnerships formed because of ADNI to continue to improve the understanding and treatment of Alzheimer’s disease.
Preparing for the Future of HIV/AIDS in Africa: A Shared ...
Released: November 29, 2010
HIV/AIDS is a catastrophe globally but nowhere more so than in sub-Saharan Africa, which in 2009 accounted for 68 percent of cases worldwide and 69 percent of new infections. The IOM recommends that the United States and African nations move toward a strategy of shared responsibility such that these nations are empowered to take ownership of their HIV/AIDS problem and work to solve it.
Rare Diseases and Orphan Products: Accelerating Research ...
Released: October 04, 2010
Rare diseases collectively affect millions of Americans of all ages, but developing drugs and medical devices to prevent, diagnose, and treat these conditions is challenging. The IOM recommends implementing an integrated national strategy to promote rare diseases research and product development.
Antibiotic Resistance: Implications for Global Health and ...
Released: September 07, 2010
Years of using, misusing, and overusing antibiotics and other antimicrobial drugs has led to the emergence of multidrug-resistant “superbugs.” The IOM’s Forum on Microbial Threats held a public workshop April 6-7 to discuss the nature and sources of drug-resistant pathogens, the implications for global health, and the strategies to lessen the current and future impact of these superbugs.
Extending the Spectrum of Precompetitive Collaboration in ...
Released: July 22, 2010
The IOM’s National Cancer Policy Forum held a workshop February 9-10, 2010, to explore the growing importance of precompetitive collaboration in oncology drug development. Speakers discussed the advantages and challenges of collaborating with competitors to achieve goals with the potential to benefit everyone, and offered lessons learned and best practices to facilitate future precompetitive collaboration.